Finance

Lists
Q3 2026 earnings • released • EPS met 0.00% • Revenue miss -0.40%
See results
CLN:WSE
Celon Pharma SA
PLN 15.44
-1.28%
(-0.20) 1D
Nov 20, 5:00:00 PM GMT+1  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
PLN 15.70
High
PLN 15.96
Low
PLN 15.32
Mkt. cap
832.39M
Avg. vol.
31.91K
Volume
19.48K
P/E ratio
8.05
52-wk high
PLN 23.50
52-wk low
PLN 15.20
EPS
PLN 1.92
Shares outstanding
53.91M
No. of employees
572
Open
PLN 15.70
High
PLN 15.96
Low
PLN 15.32
Mkt. cap
832.39M
Avg. vol.
31.91K
Volume
19.48K
P/E ratio
8.05
52-wk high
PLN 23.50
52-wk low
PLN 15.20
EPS
PLN 1.92
Shares outstanding
53.91M
No. of employees
572
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees572
Founded2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 18, 2026
Fiscal period
Q3 2026
PLN 0.08 / -
0.00%miss
Revenue / Est. (PLN)
63.25M / 63.50M
-0.40%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
66.67M
65.26M
55.57M
63.25M
Cost of goods sold
11.54M
16.70M
14.92M
16.86M
Cost of revenue
11.54M
16.70M
14.92M
16.86M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.44M
36.08M
38.62M
31.80M
Operating expense
52.60M
54.54M
50.11M
48.88M
Total operating expenses
64.14M
71.23M
65.04M
65.74M
Operating income
2.53M
-5.98M
-9.46M
-2.49M
Other non operating income
-250.00K
169.05M
3.48M
179.00K
EBT including unusual items
-6.57M
160.34M
-7.38M
-3.50M
EBT excluding unusual items
-6.57M
160.34M
-7.38M
-3.50M
Income tax expense
18.33M
1.70M
23.21M
-
Effective tax rate
-279.14%
1.06%
-314.48%
-
Other operating expenses
6.37M
7.33M
1.36M
7.26M
Net income
-24.90M
158.64M
-30.59M
-3.50M
Net profit margin
-37.35%
243.09%
-55.05%
-5.54%
Earnings per share
-
-
-
-
Interest and investment income
149.00K
151.00K
151.00K
-
Interest expense
-341.00K
-915.00K
-1.55M
-1.20M
Net interest expenses
-192.00K
-764.00K
-1.40M
-1.20M
Depreciation and amortization charges
10.78M
11.13M
10.13M
9.82M
EBITDA
11.40M
3.44M
-748.00K
10.47M
Gain or loss from assets sale
-2.91M
-569.00K
716.00K
6.88M
Upcoming events
AI content may include mistakes. Learn more
Google apps